MILFORD, Mass., May 25, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, today announced that the Company will present at the following upcoming investor conferences:
- The Marcum MicroCap Conference on Thursday, June 2, 2016, at 2:30 pm Eastern Time at the Grand Hyatt in New York City
- The JMP Securities Life Sciences Conference on Tuesday, June 21, 2016, at 10:30 am Eastern Time at The St. Regis in New York City
Live audio webcasts of the presentations will be available on the company’s website at http://ir.springbankpharm.com. Replays of the webcasts will be available for 90 days.
About Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform. The company is developing its most advanced SMNH product candidate, SB 9200, for the treatment of viral diseases, including hepatitis B virus.
Spring Bank Pharmaceuticals, Inc.
Jonathan P. Freve
Chief Financial Officer
Source:Spring Bank Pharmaceuticals Inc.